ReviewBlood and lymphatic cancer : targets and therapy2022

Use of BTK Inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Practical Guidance.

Frédérique St-Pierre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.